Hhlr Advisors, Ltd. Kodiak Sciences Inc. Transaction History

Hhlr Advisors, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$81.97 - $106.94 $66.4 Million - $86.6 Million	-810,207 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$77.2 - $126.54 $6.05 Million - $9.92 Million	-78,420 Reduced 8.82%	810,207 $75.3 Million
Q1 2021 May 17, 2021	SELL	$110.45 - $164.47 $29.7 Million - $44.2 Million	-268,780 Reduced 23.22%	888,627 $101 Million
Q4 2020 Feb 12, 2021	BUY	$60.78 - $154.03 $70.3 Million - $178 Million	1,157,407 New	1,157,407 $170 Million

112

43M

87.8K

7.3K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $122M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.